870842-23-2

Basic information

• Product Name: N-BOC-3-AZA-HEPTAN-1-ONE
• Synonyms: N-BOC-3-AZA-HEPTAN-1-ONE;1-BOC-3-OXOAZEPANE;N-Boc-3-azacycloheptan-1-one;Azepan-3-one, N-BOC protected;tert-Butyl 3-oxoazepane-1-carboxylate, 1-(tert-Butoxycarbonyl)-3-oxoazepane, 1-(tert-Butoxycarbonyl)-3-oxohomopiperidine
• CAS NO: 870842-23-2
• Molecular Formula: C₁₁H₁₉NO₃
• Molecular Weight: 213.27
• Product Categories: Carbonyl Compounds;Heterocycles
• Mol File: 870842-23-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 308.2 °C at 760 mmHg
• Flash Point: 140.2 °C
• Appearance: /
• Density: 1.072 g/cm³
• Vapor Pressure: 0.00069mmHg at 25°C
• Refractive Index: 1.476
• Storage Temp.: 2-8°C
• PKA: -1.63±0.20(Predicted)
• CAS DataBase Reference: N-BOC-3-AZA-HEPTAN-1-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: N-BOC-3-AZA-HEPTAN-1-ONE(870842-23-2)
• EPA Substance Registry System: N-BOC-3-AZA-HEPTAN-1-ONE(870842-23-2)

Safety Data

• Hazardous Substances Data: 870842-23-2(Hazardous Substances Data)

Usage

General Description

N-BOC-3-AZA-HEPTAN-1-ONE is a chemical compound with the formula C12H21NO3. It is a derivative of heptan-1-one, which is a ketone compound. The "N-BOC" in its name refers to the presence of a tert-butoxycarbonyl (BOC) protecting group on the nitrogen atom. This protecting group is often used in organic synthesis to prevent unwanted reactions at the nitrogen atom. The "3-AZA" indicates the presence of a three-carbon azabicyclic ring in the molecule. N-BOC-3-AZA-HEPTAN-1-ONE is commonly used as a building block in the synthesis of other organic compounds, particularly in the pharmaceutical and agrochemical industries.

InChI:InChI=1/C11H19NO3/c1-11(2,3)15-10(14)12-7-5-4-6-9(13)8-12/h4-8H2,1-3H3

Upstream product

• 171257-01-5 ε-caprolactam 
• 24424-99-5 di-tert-butyl dicarbonate 
• 2323-81-1 ethyl 5-chloropentanoate 
• 146407-32-1 1-benzylazepan-3-one 
• 478841-09-7 1-benzyl-3-oxoazacycloheptane-4-carboxylic acid ethyl ester 
• 478841-07-5 ethyl 5-(benzyl(2-ethoxy-2-oxoethyl)amino)valerate 
• 85908-96-9 2-oxopiperidine-1-carboxylic acid tert-butyl ester 
• 675-20-7 piperidin-2-one 
• 1179348-71-0 C₁₃H₂₅NO₄S 

Downstream Products

• 124932-43-0 (R)-(+)-3-Amino-hexahydro-1H-azepin 
• 1613401-77-6 tert-Butyl 7-(4-(benzyloxy)-2-oxopyridin-1(2H)-yl)-4,5-dihydro-1H-benzofuro[2,3-c]azepine-2(3H)-carboxylate 
• 478841-10-0 1,1-dimethylethyl 3-hydroxy-hexahydro-1H-azepine-1-carboxylate 

Relevant articles and documents

Method for preparing beixifloxacin intermediate compound

The invention provides a method for preparing a beixifloxacin intermediate compound VI. The method comprises the steps of: reacting a compound of a formula III with an upper protective group, an aminotransferase catalying and a deprotecting group to obtain a compound shown in a formula VI. The method can be used for preparing the beixifloxacin intermediate compound VI rapidly and effectively. Rawmaterials are simple and easy to obtain, the reaction is simple and easy to operate, harsh reaction conditions are not required, a production period is short, yield of a target product is high, separation and purification of the target product are simple, optical purity is high, the method is easy to achieve mass production.

AZOCANE AND AZONANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.